UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE
OMB APPROVAL
OMB Number:3235-0006
Expires:July 31, 2015
Estimated average burden
hours per response:23.8
Report for the Calendar Year or Quarter Ended:
03-31-2023
Check here if Amendment: ☐ Amendment Number:
This Amendment (Check only one.):☐ is a restatement.
☐ adds new holdings entries.

Institutional Investment Manager Filing this Report:

Name:
Krensavage Asset Management, LLC
Address:
610 FIFTH AVENUE
SUITE 301
NEW YORK, NY 10020
Form 13F File Number:
028-16807

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.


Person Signing this Report on Behalf of Reporting Manager:
Name:
Paul J. Paolino
Title:
Chief Financial Officer/Chief Compliance Officer
Phone:
212-518-3193


Signature, Place, and Date of Signing:

/s/ Paul J. Paolino
                         [Signature]
New York, NEW YORK
                 [City, State]
05-15-2023
                           [Date]
                          

Report Type (Check only one.):

☒ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) 

☐ 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) 

☐ 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)


Form 13F Summary Page

Report Summary:

Number of Other Included Managers:
0
Form 13F Information table Entry Total:
12
Form 13F Information table Value Total:
329274
          (thousands)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

  
NONE


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number:3235-0006
Expires:July 31, 2015
Estimated average burden
hours per response:23.8
COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
ALKERMES PLCCOMG0176710539,3481,395,797SHSOLE1,395,797 0 0
BIOGEN INCCOM09062X10349,246177,126SHSOLE177,126 0 0
CARDINAL HEALTH INCCOM14149Y10826,672353,278SHSOLE353,278 0 0
EAGLE PHARMACEUTICALS INCCOM2697961083,227113,737SHSOLE113,737 0 0
EMBECTA CORPCOM29082K10529,8671,062,123SHSOLE1,062,123 0 0
ENANTA PHARMACEUTICALS INCCOM29251M10624,397603,301SHSOLE603,301 0 0
EXELIXIS INCCOM30161Q10441,4572,135,868SHSOLE2,135,868 0 0
KODIAK SCIENCES INCCOM50015M1092,849459,489SHSOLE459,489 0 0
REGENERON PHARMACEUTICALSCOM75886F10748,88059,488SHSOLE59,488 0 0
TARO PHARMACEUTICAL INDUSCOMM8737E10815,611641,910SHSOLE641,910 0 0
UNITED THERAPEUTICS CORPCOM91307C10245,265202,110SHSOLE202,110 0 0
VANDA PHARMACEUTICALS INCCOM9216591082,455361,560SHSOLE361,560 0 0